Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia-Reference-Cited by-同舟云学术

Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia

Published:2017-01 Issue:1 Volume:23 Page:65-67
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Sugimoto Naomi,Yamagishi Yuka,Mikamo Hiroshige

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference15 articles.

1. Prevalence and molecular characterization of CTX-M extended-spectrum β-lactamase-producing Escherichia coli from 2000 to 2010 in Japan;Hara;Jpn J Antibiot,2015

2. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan;Nakamura;Am J Clin Pathol,2012

3. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan;Kanayama;Int J Antimicrob Agents,2015

4. Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012;Yamaguchi;Jpn J Antibiot,2014

5. Community spread of extended-spectrum β-lactamase-producing bacteria detected in social insurance hospitals throughout Japan;Shibasaki;J Infect Chemother,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?;Healthcare;2022-05-05

2. Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae;Mediterranean Journal of Infection Microbes and Antimicrobials;2020-07-21

3. Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia;Antibiotics;2020-03-06

4. Mortality caused by extended-spectrum beta-lactamase–producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam;Diagnostic Microbiology and Infectious Disease;2019-07

5. Frequent isolation of extended-spectrum beta-lactamase-producing bacteria from fecal samples of individuals with severe motor and intellectual disabilities;Journal of Infection and Chemotherapy;2018-03